Objective: Mesenteric fat is drained by the portal circulation and has been suggested to be a key component in obesity-related health risk, notably the metabolic syndrome. There are increasing epidemiological and experimental data showing that fatty liver is another component of this multifaceted syndrome. Given their intimate anatomical and physiological relationships, we hypothesized that mesenteric fat thickness may be independently associated with the risk of fatty liver. To test this hypothesis, we examined the predictive role of various fat deposits including mesenteric fat thickness, and various metabolic variables on the risk of fatty liver. Subjects and methods: A total of 291 Chinese subjects (134 men and 157 women with a mean BMI of 23.7 kg/m 2 , range: 16.5-33.4 kg/m 2 ) underwent ultrasound examination for measurement of mesenteric, subcutaneous and preperitoneal fat thickness, and for diagnosis of fatty liver. Body mass index, waist circumference, and waist-hip ratio were recorded. Blood pressure was measured. Fasting plasma glucose, insulin resistance, high-density lipoprotein cholesterol (HDL-C), triglycerides, low-density lipoprotein cholesterol (LDL-C), liver enzymes were determined by common methods. Results: The subjects with fatty liver had greater abdominal fat thickness and higher anthropometric indexes than those without fatty liver. The subjects with fatty liver also showed higher blood pressure, worse lipid and glycaemic profile compared with those without fatty liver. Using multiple logistic regression analysis, mesenteric fat thickness was a risk factor of fatty liver, independent of body mass index, age, sex, insulin resistance, fasting plasma glucose, lipid and blood pressure. The odds ratio was 1.5 (95% confidence interval: 1.27-1.77) for every 1 mm increase in the mesenteric fat thickness. Measurement of preperitoneal and subcutaneous fat deposits did not show significant associations with fatty liver. Conclusion: Mesenteric fat thickness measured on ultrasound is an independent determinant of fatty liver.
Introduction
Hepatic steatosis is frequently found in obese individuals and caused by intrahepatic accumulation of lipids. 1 The exact pathogenesis is still not fully understood 2 but probably multifactorial and related to varying combinations of increased flux of free fatty acid to liver and reduced lipid oxidation. 3 Many studies have shown that fatty liver is associated with increased visceral fat accumulation as determined by anthropometric indexes [4] [5] [6] and ratio of visceral to subcutaneous fat thickness on imaging. 1, 7 These studies have shown that adipose tissue, especially visceral type, plays an important role in the pathogenesis of fatty liver. Mesenteric fat is a specific type of visceral adipose tissue which is drained by the portal circulation, and has been shown to exhibit different metabolic characteristics compared to other types of adipose tissues such as subcutaneous and retroperitoneal fat. 8 We have previously reported that the thickness of mesenteric fat measured on ultrasound scan was a more specific deposit of visceral fat and had a good correlation with cardiovascular risk factors in healthy individuals. 9 This study aims to explore the relationships between risk of fatty liver and mesenteric fat thickness as measured on ultrasound scan.
Subjects and methods
A total of 291 Chinese subjects were recruited (134 men and 157 women with a mean BMI of 23. . In all, 254 of them were recruited through a health-screening programme and 37 were volunteers. All subjects had alcohol intake o20 g of ethanol per day, as elicited by a structured interview concerning dietary habits, substance use, and medical history by research nurse. None of the subjects had present or past history of hepatitis, and serology work up to rule out hepatitis was not specifically conducted. None of them were receiving medications known to affect the liver. The study was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong and all subjects gave informed written consents.
All subjects underwent ultrasound examination of abdomen. An ATL HDI 5000 (CA, Bothell) with CL 4-7 MHz or CL 2-5 MHz curvilinear transducer was used for the study. The methodology for measurement of mesenteric, preperitoneal and subcutaneous fat thickness had been described in detail previously. 9 In brief, a complete survey examination, with emphasis in the para-umbilical area, was performed in each subject with special attention to identify the mesenteric leaves ( Figure 1 ). The mesenteric leaves appeared to be elongated structures with highly reflecting peritoneal surfaces. The mesenteric leaves were divided from each other by specular echoes corresponding to their peritoneal surfaces. 10 When different mesenteric leaves were visualized, the maximum thickness was measured. Usually six to ten measurements were made on each ultrasound examination, and the mean of the three thickest mesenteric leaves was used for the analysis. Preperitoneal fat thickness (Figure 2) was measured with the L5-12 MHz linear transducer longitudinally, and the subcutaneous fat thickness ( Figure 3) was measured with the same transducer transversely placed perpendicular to the skin in the midline of abdomen, between the xiphoid process and umbilicus. The maximum thickness of the preperitoneal fat and subcutaneous fat was measured three times and the mean value was taken.
Fatty liver was diagnosed according to the criteria of Scatarige JC et al. 11 These criteria included increase in hepatic echogenicity, decreased penetration of deep part of liver, impaired visualization of diaphragm and intrahepatic vessels. The subjects were classified into either fatty or nonfatty group. A total of 17 subjects were examined by two experienced operators, who did not have knowledge of the other operator's scanning results. The diagnosis of fatty liver was Mesenteric fat thickness an independent determinant of fatty liver KH Liu et al made by each operator with the above-mentioned procedure. The inter-operator reliability for diagnosis of fatty liver was assessed. The intraclass correlation coefficients for the measurement of mesenteric, preperitoneal and subcutaneous fat thickness by the same operators as in the previous study 9 were reported to be ranged from 0.89 to 0.97. All subjects, wearing light clothing and no shoes, were weighed and their standing height was measured. Body mass index was calculated by body weight in kilogram divided by (body height in metre). 2 Waist circumference (WC) was measured at the narrowest circumference between xiphisternum and umbilicus. Hip circumference (HC) was measured at the maximum circumference at the level of femoral trochanter. 12 Waist-hip ratio was calculated by WC divided by HC. All subjects had blood taken after a 12-h fasting period for measurement of high-density lipoprotein cholesterol (HDL-C), triglycerides, low-density lipoprotein cholesterol (LDL-C), liver enzymes and plasma glucose. Plasma glucose (hexokinase method), total cholesterol (TC, enzymatic method), triglycerides (TG, enzymatic method without glycerol blanking), high-density lipoprotein cholesterol (HDL-C, dextran sulphate-MgCl 2 precipitation) were measured on a Hitachi 911 automated analyzer (Boehringer Mannheim, Germany) using reagent kits supplied by the manufacturer of the analyzer. LDL-C was calculated by the Friedewald's equation for TGo4.5 mmol/l. The precision performance of these assays was within the manufacturer's specifications. Insulin was measured using radioimmunoassay (DAKO insulin, Code No. K6219, DAKO, UK). The detection limit was 0.5 mIU/ml. The intra-and inter-assay CVs were 7.5 and 8.9%, respectively. Insulin resistance was estimated using the homeostasis model assessment (HOMA) equation, which equals to fasting plasma insulin-glucose product divided by 22.5. At the same setting of blood taking, blood pressure was measured using a standard mercury sphygmomanometer after sitting for at least 10 min. The Korotkoff sound V was taken as the diastolic blood pressure.
Statistical analysis
All data are expressed as means7s.d. Student's t tests were used for comparing all mean values, and w 2 was used for comparing frequency of fatty liver in men and women groups. A two-tailed P-value o0.05 was considered significant. Kappa statistics were used to assess the reliability of the sonographic diagnosis of fatty liver. Multiple logistic regression analysis was performed to identify the independent determinants for fatty liver, with sex, age, various abdominal fat thickness and metabolic variables as independent variables in one regression model. Body mass index was also included as independent variable in another logistic regression model. Waist circumference was not included in the regression model as it was highly correlated with the body mass index (r ¼ 0.89, Po0.001).
Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS) for windows, version 9.0.
Results
The sonographic diagnosis of fatty liver showed very good inter-operator reliability, with value of k ¼ 1. Men were slightly older than women and had a higher frequency of fatty liver than women. Men also had greater mesenteric and preperitoneal fat thickness than women, and vice versa for subcutaneous fat (Table 1) . Moderate correlation was found between abdominal fat thickness and anthropometric indexes ( Table 2 ). The subjects with fatty liver had greater mesenteric, preperitoneal and subcutaneous fat thickness than those without fatty liver ( Table 3 ). The subjects with fatty liver also had higher body mass index, higher blood pressure, higher liver enzyme level, worse lipid and glycaemic profiles compared with those without fatty liver.
By multiple logistic regression analysis, mesenteric fat thickness is the only abdominal fat thickness which showed significant association with fatty liver with the odds ratio 1.5 for every 1 mm increase in the mesenteric fat thickness ( Table 4 ). The measurement of other fat deposits did not show associations with fatty liver. The other independent risk factors for fatty liver were insulin resistance and triglycerides. When the body mass index was included in 
Discussion
It is well documented that fatty liver is associated with obesity, and many studies have shown that increased body mass index, waist circumference and waist-hip ratio [4] [5] [6] 13 were correlated with higher risk of fatty liver. The abdominal wall fat index expressed as a ratio of preperitoneal to subcutaneous fat thickness has been developed to assess the relationships between adipose tissue and obesity-related complications. 1, 7, 22 These sonographic measurements or indexes also showed significant associations with fatty liver or cardiovascular risk factors. However, these fat deposits are not usually regarded as visceral fat drained by the portal system. Mesenteric and omental fat are regarded as portal adipose tissues. Previous study showed that morbidly obese patients with resection of omentum showed better improvement in metabolic profile than the control group. 24 We have recently reported the independent predictive role of mesenteric fat thickness on multiple cardiovascular risk factors in a small cohort of apparently healthy Chinese subjects. 9 Mesenteric fat can be easily recognized by ultrasound scan, as illustrated in previous in vitro and in vivo study by Derchi et al. 10 Large amounts of mesenteric fat in obese subjects do not cause technical insufficiency of ultrasound examination, but on the contrary are easier to be demonstrated. 10 The conventional visceral fat volume measure- Model 1: mesenteric, preperitoneal and subcutaneous fat thickness, sex, age, systolic and diastolic blood pressure, fasting plasma glucose, insulin resistance (HOMA), low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, alkaline phosphatase, ALT/GPT were included as independent variables.Model 2: All variables in model 1+body mass index as independent variables. CI ¼ confidence intervals; NA ¼ not applicable.
Mesenteric fat thickness an independent determinant of fatty liver KH Liu et al ment on MRI scan also includes mesenteric adipose tissues, but it showed only moderate correlation (r ¼ 0.8) (unpublished data) with mesenteric fat thickness 9 which, on the other hand, was a better correlate with some of the cardiovascular risk factors. 9 This might be explained by the fact that the visceral fat determined by MRI was not fully representative of portal adipose tissue since it included nonportal adipose tissues such as preperitoneal and retroperitoneal adipose tissue.
In this study, we have shown for the first time the usefulness of sonographic measurement of mesenteric fat thickness in predicting the risk of fatty liver. In fact, ultrasound scan is currently the only imaging method which can visualize the individual mesenteric leaves, especially when they are thick and contain fat. 10 On univariate analysis, the subjects with fatty liver had higher values of abdominal fat (subcutaneous, preperitoneal and mesenteric) thickness and body mass index than those without. These findings were in keeping with the fact that fatty liver is positively related to obesity. 1 The subjects with fatty liver also had higher insulin resistance, fasting plasma glucose, blood pressure, liver enzymes, and worse lipid profile than those without fatty liver. These findings were also in line with previous observation that fatty liver is associated with worse metabolic risk profile. [25] [26] [27] [28] [29] On multiple logistic regression, mesenteric fat thickness was the only abdominal fat deposit which showed significant association with fatty liver, independent of thickness of other abdominal fat deposits, body mass index, insulin resistance, lipid and blood pressure. These results are in line with the known metabolic properties of mesenteric fat which is directly drained by the portal vein (portal adipose tissue).
30,31
Mesenteric fat is metabolically more active than subcutaneous and preperitoneal fat which are nonportal adipose tissues. Mesenteric adipocytes are more sensitive to lipolytic effects of catecholamines and are more resistant to the antilypolytic effects of insulin. 30, 31 The increased amount of mesenteric adipose tissue is expected to result in increased free fatty acid flux from portal veins to liver. 32, 33 The increased free fatty acid production may lead to reduced fat oxidation and ectopic fat deposition in liver. 30, 31 Besides, visceral adipocytes are known to produce a large number of cytokines and vasoactive peptides such as interleukin-6, angiotensin II, plasminogen activator inhibitor-I, which can also be related to the fatty liver and increase of cardiovascular risk. 34 The understanding of the relationships between mesenteric fat thickness and fatty liver may contribute to our further understanding of the pathogenesis of fatty liver. The subcutaneous and preperitoneal fat deposits are nonportal adipose tissues with lower lipolytic activities, which have lower impact on metabolic risk profile 9,35-37 compared to the visceral or portal fat. But some recent studies still showed that these nonportal adipose tissue had significant contribution to worsening metabolic risk profile, particularly when the subcutaneous fat is further divided into superficial and deep compartments with the latter shown to be independently associated with insulin resistance and explaining more variance of fasting glucose than visceral fat deposits on computed tomography studies. 38, 39 In view that there is interrelationships among obesity, fatty liver and worsening metabolic risk profile, [40] [41] [42] future studies may be needed to further compare these fat deposits (particularly when the subcutaneous fat is subdivided into superficial and deep compartments) in the association with fatty liver and metabolic risk profile. In this study, insulin resistance was not a strong predictor of having fatty liver as observed in previous study, 28, 29 which was controlled when body mass index was included in the regression model. This might be due to different ethnic groups or less obese subjects included in this study. The role of gender in fatty liver is still controversial as male or female preponderance of fatty liver was shown in different studies. [43] [44] [45] In this study, fatty liver is more prevalent in men than in women, and this might be because men were more obese than women subjects in this study. Gender difference was demonstrated between subjects with fatty and nonfatty liver. However, it was not independently associated with fatty liver on multivariate analysis, suggesting that gender difference might be the effect of obesity or increased triglycerides, rather than being directly involved in the pathogenesis of fatty liver. In this study, mesenteric fat thickness has been shown to be a predictor of fatty liver although ultrasound scan cannot differentiate between steatohepatits and simple steatosis. On the other hand, the diagnosis of fatty liver was based on sonographic findings. Admittedly, histological result remains the gold standard for the diagnosis of fatty liver. Previous studies in which ultrasound findings were compared to histologic results showed that the overall sensitivity and specificity of ultrasound examination for diagnosis of fatty liver were approximately 80-95% and 90-95%, respectively. [46] [47] [48] [49] [50] [51] Moreover, due to sampling errors, liver biopsies are reported as normal in subjects with focal fatty infiltration of the liver (approximately 5-10%). 52 Besides, due to ethical reason, liver biopsy cannot be performed in these relatively healthy individuals without overt liver abnormality. In this study, there was limitation that serology test for ruling out viral hepatitis was not specifically conducted. Although local studies have shown that hepatitis B was the more prevalent form than hepatitis C which was reported to be much more commonly associated with fatty liver, 53,54 the viral cause of fatty liver could not be excluded in this study.
In conclusion, mesenteric fat thickness measured on ultrasound was shown to be an independent determinant of fatty liver, which is increasingly recognized as part of the multifaceted metabolic syndrome. 55 
